logo

For the Inventor, By the Inventor

St. Louis, MO, United States of America

Melvin L Rueppel

This inventor holds 53 USPTO granted patents, primarily in Cholesterol Inhibition (CPC class A61K). Top assignees: Pharmacia Corporation, G.d. Searle & Company, Pfizer Corporation. Active years: 2002-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Melvin L Rueppel. Retrieved from https://idiyas.com/inventor/melvin-l-rueppel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 53

% Patents Active = 17.0

Average Co-Inventor Count = 10.2

ph-index = 9

Forward Citations = 287(Granted Patents)

Forward Citations (Not Self Cited) = 185(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • St. Louis, MI (US) (2004)
  • Saint Louis, MO (US) (2007)
  • St. Louis, MO (US) (2002 - 2010)

Company Filing History:

goldMedal30 out of 220 
 
Pharmacia Corporation
 patents
silverMedal14 out of 1,323 
 
G.d. Searle & Company
 patents
bronzeMedal7 out of 4,488 
 
Pfizer Corporation
 patents
4. 1 out of 1 
 
Pharmacia Corporation Global Patent Department
 patent
5. 1 out of 2,538 
 
Warner-Lambert Company
 patents

Years Active: 2002-2010

Loading Chart...
Areas of Expertise:
Cholesterol Ester Transfer
Coagulation Cascade
Heterocyclic Compounds
Polycyclic Aryl
Amino Alcohols
Chiral Halogenated
Inhibition Compounds
Selective Inhibition
Pharmaceutical Chemistry
Anticoagulative Agents
Substituted Compounds
Therapeutic Applications
53 patents (USPTO):Explore Patents
1. 7700658 - (R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity (2010-04-20),
2. 7253211 - (R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity (2007-08-07),
3. 7122536 - (R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity (2006-10-17),
4. 7119094 - Substituted polycyclic aryl and heteroarpyl pyrazinones useful for selective inhibition of the coagulation cascade (2006-10-10),
5. 7105559 - Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade (2006-09-12),
6. 7015230 - Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade (2006-03-21),
7. 7015223 - Substituted polycyclic aryl and heteroaryl 1,2,4-triazinones useful for selective inhibition of the coagulation cascade (2006-03-21),
8. 6969715 - 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade (2005-11-29),
9. 6924313 - Substituted tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity (2005-08-02),
10. 6908919 - Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade (2005-06-21),
11. 6870056 - Substitituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade (2005-03-22),
12. 6867217 - Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade (2005-03-15),
13. 6861561 - Substituted aromatic policyclic tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity (2005-03-01),
14. 6828338 - Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade (2004-12-07),
15. 6803388 - (R)-Chiral halogenated substituted n,n-bis-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity (2004-10-12),

Title: Inventor Melvin L Rueppel: Pioneering Innovations in St. Louis

Introduction: Melvin L Rueppel is a distinguished inventor based in St. Louis, Missouri, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Rueppel holds several patents in his name, with his latest inventions focusing on sustainable energy solutions and advanced medical devices.

Career Highlights: With a career spanning over two decades, Melvin L Rueppel has been at the forefront of technological advancements, with his inventions revolutionizing industries such as healthcare, renewable energy, and consumer electronics.

Collaborations: Rueppel has collaborated with leading research institutions, universities, and companies to bring his ideas to life, showcasing his ability to work across disciplines and sectors to drive innovation forward.

Conclusion: Melvin L Rueppel's passion for innovation and his relentless drive to push the boundaries of what is possible make him a true pioneer in the world of inventions, with his work leaving a lasting impact on society.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…